Skip to main content
. 2021 May 25;21:601. doi: 10.1186/s12885-021-08342-1

Table 3.

No nausea among enrolled patients (n = 329)

Phases No nausea (%)
Enrolled patients (n = 329) HEC (n = 260) MEC (n = 69)
Acute phase 86.01 83.46 94.20
Delayed phase 78.79 78.07 79.71
Overall phase 77.50 76.92 79.71